Shock Pathology (Cellular & Mitochondrial)

Quick Answer

Shock is a life-threatening state of circulatory failure resulting in inadequate tissue oxygen delivery (DO2) relative to oxygen consumption (VO2), leading to cellular hypoxia and organ dysfunction. At the cellular level, oxygen deprivation causes ATP depletion, failure of Na-K-ATPase pumps, cellular swelling, calcium influx, and activation of destructive enzyme cascades. Mitochondria shift from oxidative phosphorylation to anaerobic glycolysis, producing lactate and only 2 ATP per glucose versus 36-38 ATP aerobically. Prolonged hypoxia triggers mitochondrial permeability transition (MPT), reactive oxygen species (ROS) generation, and cell death via necrosis, apoptosis, necroptosis, pyroptosis, or ferroptosis. Reperfusion injury paradoxically worsens cellular damage through xanthine oxidase activation, ROS burst, neutrophil activation, and complement-mediated injury. Microcirculatory dysfunction causes heterogeneous flow with functional shunting despite normalized macrocirculation. Compensatory mechanisms (sympathetic activation, RAAS, ADH) initially maintain perfusion but ultimately decompensate, leading to irreversible shock and multi-organ dysfunction syndrome (MODS).

Key Classifications:

• Hypovolaemic: Reduced preload (haemorrhage, dehydration)
• Cardiogenic: Pump failure (MI, cardiomyopathy)
• Distributive: Vasodilation with maldistribution (sepsis, anaphylaxis, neurogenic)
• Obstructive: Mechanical obstruction (PE, tamponade, tension pneumothorax)

---

CICM Exam Focus

What Examiners Expect

The CICM First Part examination considers shock pathophysiology a core topic requiring detailed understanding of cellular and molecular mechanisms. Examiners expect candidates to demonstrate:

Written Examination (SAQ):

• Clear definition of shock emphasising cellular hypoxia rather than hypotension
• Systematic classification with pathophysiological basis for each type
• Detailed description of cellular consequences of hypoxia including ATP depletion, ion pump failure, and enzyme activation
• Understanding of anaerobic metabolism with lactate production and metabolic acidosis
• Comprehensive knowledge of mitochondrial dysfunction including electron transport chain failure and ROS production
• Explanation of cell death pathways with distinguishing features
• Description of microcirculatory dysfunction and its measurement
• Integration of biomarkers (lactate, SvO2, CO2 gap) with pathophysiology

Viva Examination:

• Systematic approach from oxygen delivery to cellular utilisation
• Ability to link basic science to clinical scenarios
• Discussion of compensatory mechanisms and their failure
• Understanding of reperfusion injury mechanisms
• Organ-specific pathology with emphasis on gut, kidney, and myocardium
• Evidence-based discussion of monitoring and endpoints

Common SAQ Stems

1. "Define shock and describe the cellular consequences of inadequate tissue oxygen delivery"
2. "Explain the pathophysiology of lactate production in shock states and its clinical significance"
3. "Describe the mechanisms of mitochondrial dysfunction in shock and the role of reactive oxygen species"
4. "Compare and contrast necrosis and apoptosis as mechanisms of cell death in shock"
5. "Explain the pathophysiology of reperfusion injury and strategies for its prevention"
6. "Describe the microcirculatory dysfunction that occurs in septic shock"
7. "Outline the compensatory mechanisms activated in haemorrhagic shock and explain how they may become detrimental"

High-Yield Topics

• Definition emphasising cellular hypoxia (not hypotension)
• ATP yield comparison: aerobic (36-38) vs anaerobic (2 ATP)
• Na-K-ATPase failure cascade and cellular consequences
• Mitochondrial permeability transition pore (MPTP)
• ROS production sites (Complex I and III)
• Cell death pathways: necrosis vs apoptosis vs necroptosis vs pyroptosis vs ferroptosis
• Reperfusion injury mechanisms: xanthine oxidase, neutrophils, complement
• Lactate physiology: production, clearance, interpretation
• ScvO2, SvO2, and venoarterial CO2 gap interpretation

---

Key Points

1. Definition of Shock: Shock is defined as inadequate tissue oxygen delivery relative to metabolic demand, resulting in cellular hypoxia and organ dysfunction - hypotension is a late and inconsistent sign (PMID: 24296998)

2. ATP Depletion: Cellular hypoxia causes rapid ATP depletion within 5-10 minutes; aerobic metabolism yields 36-38 ATP per glucose versus only 2 ATP from anaerobic glycolysis (PMID: 25559345)

3. Na-K-ATPase Failure: ATP depletion causes failure of the Na-K-ATPase pump, leading to intracellular sodium accumulation, cellular swelling, potassium efflux, and depolarisation (PMID: 16921398)

4. Calcium Overload: Failure of Ca2+-ATPase and Na-Ca exchanger reversal causes cytoplasmic calcium accumulation, activating phospholipases, proteases, and endonucleases (PMID: 10666430)

5. Mitochondrial Dysfunction: Hypoxia and calcium overload cause mitochondrial permeability transition (MPT), releasing cytochrome c and initiating both necrotic and apoptotic pathways (PMID: 17453016)

6. Lactate Production: Anaerobic glycolysis increases lactate production 10-20 fold; plasma lactate greater than 4 mmol/L indicates severe tissue hypoxia with mortality exceeding 30% (PMID: 19279318)

7. Reperfusion Injury: Restoration of blood flow paradoxically worsens injury through xanthine oxidase-mediated ROS production, neutrophil activation, and complement-mediated damage (PMID: 17303825)

8. Microcirculatory Dysfunction: Sepsis causes heterogeneous capillary flow with functional shunting, decreased functional capillary density, and impaired tissue oxygen extraction (PMID: 17452929)

9. Cell Death Pathways: Shock activates multiple cell death pathways - necrosis (uncontrolled), apoptosis (programmed), necroptosis (RIPK-mediated), pyroptosis (inflammasome), and ferroptosis (iron-dependent lipid peroxidation) (PMID: 24373423)

10. Irreversible Shock: Decompensation occurs when compensatory mechanisms fail, leading to myocardial depression, vascular unresponsiveness, and multi-organ dysfunction with mortality exceeding 70% (PMID: 16215375)

---

Definition of Shock

Classical Definition

Shock is fundamentally defined as a state of inadequate tissue oxygen delivery relative to metabolic oxygen demand, resulting in cellular hypoxia and organ dysfunction. This definition emphasises the cellular pathophysiology rather than haemodynamic parameters (PMID: 24296998).

Key definitional concepts:

• Shock is a cellular diagnosis, not a blood pressure measurement
• Hypotension is a late and inconsistent sign - shock can exist with normal blood pressure (cryptic shock)
• The core problem is imbalance between oxygen supply and demand at the cellular level
• Organ dysfunction results from cellular injury and death, not simply reduced blood flow

Oxygen Delivery-Consumption Relationship

Normal oxygen physiology:

Critical oxygen delivery:

• Normal DO2:VO2 ratio is approximately 4:1, providing physiological reserve
• Critical DO2 threshold: approximately 330 mL/min/m2 (8-10 mL/kg/min)
• Below critical DO2, oxygen consumption becomes supply-dependent
• Supply-dependency initiates anaerobic metabolism and lactate production (PMID: 2193159)

The Supply-Demand Relationship

Oxygen Delivery (DO2) = Cardiac Output x Oxygen Content (CaO2)

Where CaO2 = (Hb x 1.34 x SaO2) + (0.003 x PaO2)

Normal DO2 = 5 L/min x 200 mL O2/L = 1000 mL O2/min

Supply-dependency pathophysiology:

1. Above critical DO2: VO2 is independent of DO2 (plateau phase)
2. Below critical DO2: VO2 becomes linearly dependent on DO2
3. The transition point varies by tissue metabolic rate
4. Tissues with highest metabolic demand (brain, heart) fail first (PMID: 2193159)

---

Classification of Shock

Shock is classified into four main categories based on the primary pathophysiological mechanism. Understanding the classification enables targeted treatment (PMID: 24296998).

Hypovolaemic Shock

Definition: Decreased circulating blood volume leading to reduced venous return, cardiac preload, and cardiac output.

Pathophysiology:

• Reduced intravascular volume decreases venous return
• Frank-Starling mechanism fails with inadequate preload
• Cardiac output falls, reducing oxygen delivery
• Compensatory vasoconstriction maintains blood pressure initially

Causes:

Haemodynamic profile:

• Low CVP/PCWP (reduced preload)
• Low cardiac output
• High SVR (compensatory vasoconstriction)
• Low SvO2 (increased extraction) (PMID: 15243929)

Cardiogenic Shock

Definition: Pump failure with inability to generate adequate cardiac output despite adequate preload.

Pathophysiology:

• Primary myocardial dysfunction reduces stroke volume
• Elevated filling pressures cause pulmonary congestion
• Compensatory vasoconstriction increases afterload
• Further myocardial dysfunction creates vicious cycle

Causes:

Haemodynamic profile:

• High CVP/PCWP (elevated preload)
• Low cardiac output/cardiac index (less than 2.2 L/min/m2)
• High SVR (compensatory)
• Low SvO2 (PMID: 10938172)

Distributive Shock

Definition: Vasodilation and maldistribution of blood flow causing inadequate tissue perfusion despite normal or elevated cardiac output.

Pathophysiology:

• Pathological vasodilation reduces SVR
• Relative hypovolaemia from increased vascular capacitance
• Maldistribution causes regional tissue hypoxia
• Cardiac output typically increased but ineffectively distributed

Subtypes:

Haemodynamic profile (septic shock):

• Low-normal CVP
• High cardiac output (hyperdynamic phase)
• Low SVR
• Variable SvO2 (may be elevated due to extraction defect) (PMID: 16855598)

Obstructive Shock

Definition: Mechanical obstruction to cardiac filling or ejection causing inadequate cardiac output.

Pathophysiology:

• Physical obstruction prevents adequate cardiac filling or output
• Compensatory mechanisms limited by mechanical constraint
• Rapid deterioration if obstruction not relieved

Causes:

Haemodynamic profile:

• Elevated CVP (except early PE)
• Low cardiac output
• High SVR
• Low SvO2 (PMID: 24296998)

---

Cellular Hypoxia and ATP Depletion

Normal Cellular Energy Metabolism

Understanding normal cellular energy metabolism is essential for appreciating the consequences of hypoxia. The mitochondria are the primary site of ATP production through oxidative phosphorylation (PMID: 25559345).

Glucose metabolism overview:

1. Glycolysis (cytoplasm):

   • Glucose to 2 pyruvate
   • Net yield: 2 ATP + 2 NADH
   • Occurs without oxygen requirement

2. Pyruvate Dehydrogenase Complex:

   • Pyruvate to acetyl-CoA
   • Located in mitochondrial matrix
   • Produces 2 NADH per glucose

3. Tricarboxylic Acid (TCA) Cycle:

   • Acetyl-CoA oxidation in mitochondrial matrix
   • Produces 6 NADH + 2 FADH2 + 2 ATP (GTP) per glucose

4. Electron Transport Chain (ETC):

   • NADH and FADH2 donate electrons
   • Protons pumped across inner mitochondrial membrane
   • ATP synthase generates ATP from proton gradient
   • Oxygen is terminal electron acceptor

ATP yield comparison:

ATP production rate: approximately 40 kg ATP/day in resting adult (PMID: 25559345)

Consequences of Hypoxia on ATP Production

When oxygen becomes limiting, the electron transport chain cannot accept electrons from NADH and FADH2, causing:

Immediate effects (seconds to minutes):

1. ETC stops at Complex IV (cytochrome c oxidase)
2. NADH/NAD+ ratio increases dramatically
3. Proton gradient dissipates
4. ATP synthase ceases production
5. Mitochondrial membrane potential decreases (PMID: 17453016)

Metabolic shift to anaerobic glycolysis:

• Pyruvate cannot enter TCA cycle (NADH cannot be oxidised)
• Lactate dehydrogenase (LDH) converts pyruvate to lactate
• This regenerates NAD+ to sustain glycolysis
• ATP production falls from 36-38 to only 2 per glucose
• Represents 18-19 fold decrease in ATP efficiency (PMID: 19279318)

Cellular ATP timeline in complete ischaemia:

Na-K-ATPase Failure and Cellular Swelling

The Na-K-ATPase pump is the most ATP-dependent cellular process, consuming approximately 30% of total cellular ATP. Its failure initiates a cascade of events (PMID: 16921398).

Normal Na-K-ATPase function:

• Pumps 3 Na+ out, 2 K+ in per ATP hydrolysed
• Maintains resting membrane potential (-70 to -90 mV)
• Creates Na+ gradient driving secondary active transport
• Maintains cell volume through osmotic balance

Consequences of pump failure:

1. Sodium accumulation:

   • Intracellular Na+ rises from 10-15 to greater than 50 mEq/L
   • Water follows osmotically
   • Cellular swelling (oncosis) occurs
   • Cell volume may increase 50-100%

2. Potassium efflux:

   • Intracellular K+ falls from 140 to less than 80 mEq/L
   • Membrane depolarises
   • Extracellular K+ rises (hyperkalaemia in systemic ischaemia)
   • Cardiac arrhythmia risk increases

3. Membrane depolarisation:

   • Resting membrane potential falls toward zero
   • Voltage-gated channels affected
   • Loss of excitability
   • Muscle and nerve dysfunction (PMID: 16921398)

Calcium Overload and Enzyme Activation

Calcium homeostasis is critically ATP-dependent. Hypoxia causes catastrophic calcium overload through multiple mechanisms (PMID: 10666430).

Normal calcium regulation:

• Cytoplasmic Ca2+: 100 nM (0.0001 mM)
• Extracellular Ca2+: 2.5 mM
• 10,000-fold gradient maintained by:
  • Plasma membrane Ca2+-ATPase (PMCA)
  • Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)
  • Na-Ca exchanger (NCX)
  • Mitochondrial Ca2+ uptake

Mechanisms of calcium overload in hypoxia:

1. PMCA failure (ATP-dependent):

   • Cannot pump Ca2+ out of cell
   • Cytoplasmic Ca2+ rises

2. SERCA failure (ATP-dependent):

   • Cannot sequester Ca2+ in ER/SR
   • ER Ca2+ stores release

3. NCX reversal:

   • Normal: 3 Na+ in, 1 Ca2+ out
   • With high intracellular Na+, exchanger reverses
   • Ca2+ enters cell via NCX

4. Voltage-gated calcium channels:

   • Depolarisation opens L-type channels
   • Ca2+ influx increases

5. Mitochondrial calcium overload:

   • Mitochondria buffer cytoplasmic Ca2+
   • Excessive uptake triggers MPTP opening (PMID: 10666430)

Consequences of elevated cytoplasmic calcium:

---

Anaerobic Metabolism and Lactate

Biochemistry of Lactate Production

Lactate is produced through the reduction of pyruvate by lactate dehydrogenase (LDH). This reaction is essential for maintaining glycolysis during hypoxia (PMID: 19279318).

Lactate dehydrogenase reaction:

Pyruvate + NADH + H+ <--> Lactate + NAD+

Purpose of lactate production:

• Regenerates NAD+ required for glycolysis
• Allows continued (albeit limited) ATP production
• Represents cellular adaptation to oxygen limitation
• Lactate is NOT a metabolic waste product - it is a fuel source

Lactate metabolism:

Normal lactate physiology:

• Resting production: 1.0-1.5 mmol/kg/day (approximately 1500 mmol/day)
• Normal plasma concentration: 0.5-1.5 mmol/L
• Hepatic clearance capacity: up to 100 mmol/hour
• Lactate turnover: 15-20 mg/kg/min (PMID: 8343063)

Type A vs Type B Lactic Acidosis

Type A lactic acidosis (hypoxic):

• Primary mechanism: Tissue hypoxia
• DO2/VO2 imbalance present
• Classic shock states

Type B lactic acidosis (non-hypoxic):

• No evidence of tissue hypoxia
• Metabolic or drug-related causes

Type B mechanisms:

• Impaired hepatic clearance (B1)
• Mitochondrial toxicity (propofol, linezolid)
• Pyruvate dehydrogenase inhibition (thiamine deficiency)
• Increased aerobic glycolysis (adrenaline, salbutamol - beta-2 effect) (PMID: 8343063)

Clinical Significance of Lactate

Prognostic value:

• Lactate is one of the strongest predictors of mortality in critical illness
• Serial measurements and lactate clearance superior to single values
• Target: lactate normalisation or greater than 10% reduction per 2 hours (PMID: 23103175)

Lactate and mortality:

Lactate clearance:

• Lactate clearance = (Lactate initial - Lactate 6h)/Lactate initial x 100%
• Clearance greater than 10% per 2 hours associated with improved survival
• Failure to clear lactate indicates ongoing tissue hypoxia or impaired clearance (PMID: 23103175)

Metabolic Acidosis in Shock

Mechanisms of acidosis:

1. Lactic acidosis:

   • Lactate anion contributes to unmeasured anion gap
   • Each mmol lactate consumes 1 mmol bicarbonate

2. ATP hydrolysis:

   • ATP -> ADP + Pi + H+
   • Net proton production during ATP depletion

3. Ketoacidosis (starvation, stress):

   • Increased lipolysis and ketogenesis
   • Beta-hydroxybutyrate and acetoacetate accumulation

4. Renal failure:

   • Reduced acid excretion
   • Decreased bicarbonate regeneration

Physiological consequences of acidosis:

pH and survival:

• pH less than 7.1 associated with markedly increased mortality
• Severe acidosis (pH less than 6.9) often incompatible with life
• However, acidosis is a marker of severity, not an independent treatment target (PMID: 26556858)

---

Mitochondrial Dysfunction

Electron Transport Chain and Oxidative Phosphorylation

The electron transport chain (ETC) consists of four multiprotein complexes (I-IV) embedded in the inner mitochondrial membrane, plus mobile electron carriers (coenzyme Q, cytochrome c) (PMID: 25559345).

ETC components:

Normal oxidative phosphorylation:

1. NADH donates electrons to Complex I
2. FADH2 donates electrons to Complex II
3. Electrons pass through CoQ to Complex III
4. Cytochrome c shuttles electrons to Complex IV
5. Complex IV reduces O2 to H2O (terminal acceptor)
6. Proton pumping creates electrochemical gradient
7. ATP synthase uses gradient to phosphorylate ADP

ATP yield:

• 10 protons pumped per NADH (yields approximately 2.5 ATP)
• 6 protons pumped per FADH2 (yields approximately 1.5 ATP)
• Total theoretical yield: 30-32 ATP per glucose (actual 26-28 ATP) (PMID: 25559345)

Hypoxic Mitochondrial Dysfunction

When oxygen becomes limiting, the ETC fails in a characteristic sequence (PMID: 17453016).

Sequence of dysfunction:

1. Complex IV inhibition (first to fail):

   • Cannot transfer electrons to O2
   • Cytochrome c remains reduced
   • Km for O2 is 0.1-0.5 mmHg (very high affinity)
   • Dysfunction begins when tissue PO2 less than 1 mmHg

2. Electron backup:

   • Electron carriers become maximally reduced
   • NADH/NAD+ ratio increases
   • Proton pumping stops

3. Membrane potential collapse:

   • Mitochondrial membrane potential (Psi m) normally -150 to -180 mV
   • Hypoxia causes depolarisation
   • Threshold for MPTP opening approached

4. ROS production paradox:

   • Partially reduced ETC components leak electrons to O2
   • Forms superoxide anion (O2.-)
   • Particularly at Complex I and III
   • Peaks during hypoxia-reoxygenation (PMID: 17453016)

Mitochondrial Permeability Transition

The mitochondrial permeability transition pore (MPTP) is a non-selective channel in the inner mitochondrial membrane that opens under conditions of cellular stress (PMID: 18280258).

MPTP structure (current understanding):

• Composition debated but includes:
  • Adenine nucleotide translocase (ANT)
  • Voltage-dependent anion channel (VDAC)
  • Cyclophilin D (regulatory component)
  • F0-F1 ATP synthase dimers
• Inner membrane location critical
• Allows molecules less than 1.5 kDa to pass

Triggers for MPTP opening:

Consequences of MPTP opening:

1. Loss of membrane potential:

   • Proton gradient dissipates
   • ATP production ceases
   • ATP synthase may reverse (consume ATP)

2. Mitochondrial swelling:

   • Water enters matrix
   • Matrix expands
   • Outer membrane ruptures

3. Cytochrome c release:

   • Initiates intrinsic apoptosis pathway
   • Activates caspase cascade
   • Point of no return for apoptosis

4. Calcium release:

   • Mitochondrial Ca2+ released to cytoplasm
   • Amplifies calcium overload

5. NAD+ depletion:

   • NAD+ exits through pore
   • Glycolysis compromised (PMID: 18280258)

Reactive Oxygen Species Production

Reactive oxygen species (ROS) are chemically reactive molecules containing oxygen. In shock, ROS production increases dramatically through multiple mechanisms (PMID: 17303825).

Major ROS species:

Sources of ROS in shock:

1. Mitochondrial ETC (Complex I and III):

   • 1-2% of electrons normally leak to form superoxide
   • Increases dramatically during hypoxia/reperfusion
   • Partially reduced carriers more likely to leak

2. Xanthine oxidase:

   • Converted from xanthine dehydrogenase during ischaemia
   • Calcium-activated protease cleaves XD to XO
   • Uses O2 to oxidise hypoxanthine
   • Major source during reperfusion

3. NADPH oxidase:

   • NOX2 in neutrophils (respiratory burst)
   • NOX4 in endothelium
   • Major contributor in sepsis

4. Uncoupled endothelial NOS:

   • Normally produces NO
   • With tetrahydrobiopterin deficiency, produces superoxide

5. Cyclooxygenase/Lipoxygenase:

   • Arachidonic acid metabolism
   • ROS as byproduct (PMID: 17303825)

Cellular damage from ROS:

Antioxidant Defence Systems

Cells possess multiple antioxidant mechanisms that become overwhelmed in shock (PMID: 21704875).

Enzymatic antioxidants:

Non-enzymatic antioxidants:

• Glutathione (GSH) - major intracellular antioxidant
• Vitamin E (tocopherol) - lipid-soluble, membrane protection
• Vitamin C (ascorbate) - water-soluble, regenerates vitamin E
• Uric acid - extracellular antioxidant
• Bilirubin - physiological antioxidant

Failure in shock:

• Antioxidant capacity overwhelmed by ROS production
• GSH depleted; GSSG accumulates
• Oxidised proteins accumulate
• Oxidative stress propagates injury (PMID: 21704875)

---

Reperfusion Injury

Mechanisms of Reperfusion Injury

Paradoxically, restoration of blood flow to ischaemic tissue causes additional injury beyond that from ischaemia alone. This phenomenon is termed ischaemia-reperfusion (I/R) injury (PMID: 17303825).

The oxygen paradox:

• Reintroduction of oxygen to hypoxic tissue
• Partially reduced ETC components now have O2 available
• Massive ROS production within seconds of reperfusion
• ROS burst causes additional tissue damage

Key mechanisms:

1. Xanthine oxidase pathway:

   • During ischaemia:
     • ATP -> ADP -> AMP -> adenosine -> inosine -> hypoxanthine (accumulates)
     • Ca2+-activated proteases convert xanthine dehydrogenase (XD) to xanthine oxidase (XO)
   • Upon reperfusion:
     • XO oxidises hypoxanthine to xanthine to uric acid
     • Uses O2 as electron acceptor
     • Produces superoxide and H2O2
   • This pathway accounts for 50-70% of reperfusion ROS (PMID: 17303825)

2. Mitochondrial ROS burst:

   • Reduced ETC components react with reintroduced O2
   • Complex I and III major sources
   • MPTP opening releases ROS to cytoplasm

3. NADPH oxidase activation:

   • Neutrophils activated during ischaemia
   • Reperfusion delivers activated neutrophils
   • Respiratory burst in tissue
   • Myeloperoxidase generates hypochlorous acid (HOCl)

Neutrophil-Mediated Injury

Neutrophils are central effectors of reperfusion injury, particularly in myocardial and intestinal I/R (PMID: 19399221).

Neutrophil activation cascade:

1. Priming (during ischaemia):

   • Cytokines (TNF-alpha, IL-1, IL-6) prime neutrophils
   • Increased expression of adhesion molecules
   • Enhanced responsiveness to activating stimuli

2. Adhesion and rolling:

   • Selectins (E-selectin, P-selectin) on activated endothelium
   • L-selectin on neutrophils
   • Slows neutrophils in post-capillary venules

3. Firm adhesion:

   • Beta-2 integrins (CD11/CD18) on neutrophils
   • ICAM-1, VCAM-1 on endothelium
   • Firm attachment prevents further flow

4. Transmigration:

   • Neutrophils cross endothelium (diapedesis)
   • PECAM-1 mediates transmigration
   • Enter tissue parenchyma

5. Tissue injury:

   • Respiratory burst (NADPH oxidase)
   • Degranulation (elastase, MPO, cathepsins)
   • NETs (neutrophil extracellular traps)
   • Cytokine release (PMID: 19399221)

Complement Activation

The complement system is activated during I/R injury through multiple pathways (PMID: 23358542).

Complement pathways in I/R:

1. Classical pathway:

   • IgM binds modified self-antigens exposed by ischaemia
   • C1q binding initiates cascade

2. Lectin pathway:

   • Mannose-binding lectin (MBL) recognises carbohydrate patterns
   • Exposed during ischaemia
   • Major pathway in intestinal I/R

3. Alternative pathway:

   • Spontaneous C3 hydrolysis
   • Amplifies other pathways
   • Continuous low-level activation

Complement effectors:

Evidence for complement in I/R:

• Complement depletion reduces I/R injury in animal models
• C5a receptor antagonists protective
• Anti-C5 antibody (eculizumab) protective in some clinical trials (PMID: 23358542)

Endothelial Dysfunction

Endothelial cells are particularly vulnerable to I/R injury, leading to microvascular dysfunction (PMID: 12415477).

Normal endothelial functions:

• Barrier function (tight junctions)
• Anticoagulant surface
• NO production (vasodilation)
• Leukocyte trafficking regulation
• Inflammatory mediator secretion

Endothelial injury in I/R:

1. ROS-mediated damage:

   • Lipid peroxidation of membranes
   • Protein oxidation
   • DNA damage

2. NO bioavailability reduced:

   • Superoxide scavenges NO
   • Peroxynitrite formation
   • eNOS uncoupling

3. Barrier dysfunction:

   • Tight junction disruption
   • Increased permeability
   • Interstitial oedema

4. Pro-thrombotic state:

   • Tissue factor expression
   • Loss of thrombomodulin
   • Microvascular thrombosis

5. Pro-inflammatory activation:

   • Adhesion molecule expression (ICAM-1, VCAM-1, E-selectin)
   • Cytokine production
   • Chemokine secretion (PMID: 12415477)

No-Reflow Phenomenon

The no-reflow phenomenon describes failure to restore microvascular perfusion despite relief of macrovascular obstruction (PMID: 24390550).

Mechanisms:

1. Endothelial swelling: Reduces capillary lumen
2. Neutrophil plugging: Activated neutrophils occlude capillaries
3. Microthrombi: Platelet-fibrin aggregates
4. Vasospasm: Loss of NO-mediated relaxation
5. Interstitial oedema: External capillary compression
6. Pericyte contraction: Reduces capillary diameter

Clinical relevance:

• Occurs in 30-50% of acute MI patients after PCI
• Associated with larger infarct size and worse outcomes
• Current therapies have limited efficacy (PMID: 24390550)

---

Cell Death Pathways in Shock

Overview of Cell Death

Cell death in shock occurs through multiple distinct pathways, each with characteristic morphological and biochemical features. Understanding these pathways has therapeutic implications (PMID: 24373423).

Classification of cell death:

Necrosis

Necrosis is passive, uncontrolled cell death resulting from overwhelming injury with ATP depletion (PMID: 19021139).

Pathogenesis:

1. Severe ATP depletion (less than 5-10% normal)
2. Na-K-ATPase failure
3. Cellular swelling (oncosis)
4. Calcium overload
5. Enzyme activation (proteases, phospholipases)
6. Plasma membrane rupture
7. Release of intracellular contents

Morphological features:

• Cellular swelling
• Membrane blebbing
• Organelle swelling
• Nuclear pyknosis, karyolysis, or karyorrhexis
• Membrane rupture
• Eosinophilic cytoplasm (H&E)

Consequences:

• Release of DAMPs (damage-associated molecular patterns)
• Strong inflammatory response
• Tissue destruction
• Fibrosis and scarring (PMID: 19021139)

DAMPs released:

Apoptosis

Apoptosis is programmed cell death executed through caspase cascades, allowing orderly cell removal without inflammation (PMID: 17681024).

Intrinsic (mitochondrial) pathway:

1. Initiation:

   • DNA damage, hypoxia, ROS, growth factor withdrawal
   • p53 activation
   • BH3-only proteins (BID, BAD, BIM, PUMA) activated

2. Mitochondrial involvement:

   • BAX/BAK oligomerisation on outer membrane
   • Mitochondrial outer membrane permeabilisation (MOMP)
   • Cytochrome c release
   • Smac/DIABLO release (neutralises IAPs)

3. Execution:

   • Cytochrome c + Apaf-1 + procaspase-9 = apoptosome
   • Caspase-9 activated
   • Caspase-9 cleaves effector caspases (3, 6, 7)
   • Caspase-3 executes apoptosis

Extrinsic (death receptor) pathway:

1. Death ligand binds receptor (FasL-Fas, TNF-TNFR, TRAIL-DR4/5)
2. Receptor trimerisation
3. DISC (death-inducing signalling complex) formation
4. Procaspase-8 recruited and activated
5. Caspase-8 activates caspase-3 directly (Type I cells)
6. Or caspase-8 cleaves BID to tBID, activating intrinsic pathway (Type II cells)

Morphological features:

• Cell shrinkage
• Membrane blebbing
• Chromatin condensation
• Nuclear fragmentation
• Apoptotic bodies
• Phosphatidylserine externalisation (eat-me signal)
• Phagocytosis by macrophages

Apoptosis in shock:

• Lymphocyte apoptosis contributes to immunosuppression
• Endothelial apoptosis worsens microcirculatory dysfunction
• Cardiomyocyte apoptosis contributes to myocardial dysfunction
• Epithelial apoptosis promotes barrier failure (PMID: 17681024)

Necroptosis

Necroptosis is a regulated form of necrosis mediated by RIPK1, RIPK3, and MLKL. It occurs when apoptosis is inhibited but death signals are present (PMID: 28592691).

Molecular pathway:

1. Death receptor ligation (TNF-TNFR1)
2. Complex I formation (TRADD, RIPK1, cIAPs)
3. If caspase-8 inhibited (cIAP depletion, caspase inhibitors):
   • Complex IIb (ripoptosome) forms
   • RIPK1 and RIPK3 interact via RHIM domains
4. RIPK3 phosphorylates MLKL
5. pMLKL oligomerises at plasma membrane
6. Membrane pore formation
7. Cell lysis and DAMP release

Regulation:

• Caspase-8 normally cleaves and inactivates RIPK1/RIPK3
• Caspase inhibitors (IAPs, viral inhibitors) enable necroptosis
• RIPK1 kinase activity required

Necroptosis in shock:

• Contributes to TNF-induced shock
• Important in ischaemia-reperfusion injury
• Neutrophil necroptosis in sepsis
• Therapeutic target: necrostatin-1 (RIPK1 inhibitor) protective in animal models (PMID: 28592691)

Pyroptosis

Pyroptosis is inflammatory cell death mediated by inflammasomes and gasdermin D, leading to cytokine release (PMID: 27383986).

Canonical inflammasome pathway:

1. Pattern recognition receptor activation (NLRP3, AIM2, NLRC4)
2. Inflammasome complex assembly (sensor + ASC + caspase-1)
3. Caspase-1 activation
4. Caspase-1 cleaves:
   • Pro-IL-1beta to IL-1beta
   • Pro-IL-18 to IL-18
   • Gasdermin D (GSDMD)
5. GSDMD N-terminal fragment forms membrane pores
6. IL-1beta and IL-18 release through pores
7. Cell swelling and lysis

Non-canonical pathway:

1. Cytoplasmic LPS detected by caspase-4/5/11
2. Direct caspase activation (no inflammasome)
3. GSDMD cleavage
4. Pore formation

Pyroptosis in shock:

• Major pathway in sepsis
• Source of IL-1beta and IL-18
• Contributes to inflammation
• GSDMD inhibitors protective in animal sepsis models (PMID: 27383986)

Ferroptosis

Ferroptosis is iron-dependent lipid peroxidation-mediated cell death, distinct from other death pathways (PMID: 23211769).

Mechanism:

1. Iron accumulation (via transferrin receptor, ferritin degradation)
2. Labile iron pool (Fe2+) increases
3. Fe2+ catalyses Fenton reaction: Fe2+ + H2O2 -> Fe3+ + OH. + OH-
4. Hydroxyl radical initiates lipid peroxidation
5. PUFA-containing phospholipids oxidised
6. Membrane damage and cell death

Regulation:

• GPX4 (glutathione peroxidase 4): reduces lipid peroxides, protects against ferroptosis
• System Xc-: cystine/glutamate antiporter, imports cystine for glutathione synthesis
• FSP1/CoQ10: parallel antioxidant pathway

Inducers:

• Erastin (System Xc- inhibitor)
• RSL3 (GPX4 inhibitor)
• Iron overload

Ferroptosis in shock:

• Contributes to I/R injury
• Important in AKI
• Cardiomyocyte ferroptosis in myocardial I/R
• Iron chelators (deferoxamine) and lipophilic antioxidants protective (PMID: 23211769)

---

Microcirculatory Dysfunction

Normal Microcirculation

The microcirculation comprises arterioles, capillaries, and venules where oxygen delivery and nutrient exchange occur. Its function is critical for tissue viability (PMID: 17452929).

Microcirculatory anatomy:

Normal capillary function:

• Capillary density: 400-600 vessels/mm2 (varies by tissue)
• Capillary blood flow: 0.5-1.0 mm/s
• Oxygen extraction: most occurs in first 50% of capillary length
• Heterogeneous flow even in health (but all capillaries perfused)

Regulation of microcirculation:

1. Autoregulation: Myogenic response to pressure
2. Metabolic vasodilation: Adenosine, CO2, H+, K+
3. Endothelium-dependent: NO, prostacyclin
4. Neural control: Sympathetic vasoconstriction
5. Humoral factors: Catecholamines, angiotensin II (PMID: 17452929)

Microcirculatory Dysfunction in Sepsis

Septic shock causes profound microcirculatory dysfunction that persists despite macrocirculatory resuscitation (PMID: 19066471).

Hallmarks of septic microcirculatory dysfunction:

1. Decreased functional capillary density (FCD):

   • 30-50% reduction in perfused capillaries
   • Tissue areas become hypoxic despite adequate macroperfusion
   • Measurable by sidestream dark field (SDF) imaging

2. Heterogeneous flow distribution:

   • Adjacent capillaries with vastly different flow
   • Some stopped, some with normal flow
   • Creates "shunting" pathophysiology

3. Increased stopped/slow flow capillaries:

   • More than 20% capillaries with stopped or intermittent flow
   • Perfused vessel density (PVD) reduced

4. Altered glycocalyx:

   • Endothelial glycocalyx shedding
   • Increased permeability
   • Reduced shear-stress sensing

5. Endothelial dysfunction:

   • Reduced NO bioavailability
   • Increased adhesion molecule expression
   • Pro-thrombotic state (PMID: 19066471)

Haemodynamic Coherence

Haemodynamic coherence describes the relationship between macrohemodynamic resuscitation and microcirculatory perfusion. Loss of coherence is a key feature of shock (PMID: 26649802).

Types of haemodynamic incoherence:

Clinical implications:

• Normal blood pressure and cardiac output do not guarantee adequate tissue perfusion
• Persistent lactate elevation despite resuscitation may indicate microcirculatory dysfunction
• ScvO2 may be normal or elevated due to "shunting" (PMID: 26649802)

Measurement of Microcirculation

Sublingual microcirculation imaging:

Key parameters:

• TVD (Total Vessel Density): All visible vessels per mm2
• PVD (Perfused Vessel Density): Continuously perfused vessels per mm2
• PPV (Proportion of Perfused Vessels): PVD/TVD x 100%
• MFI (Microvascular Flow Index): Semiquantitative flow score (0-3)
• Heterogeneity Index: Variation in MFI between sites (PMID: 17452929)

The Oxygen Extraction Defect

In septic shock, tissues fail to extract oxygen despite adequate delivery, creating an "oxygen extraction defect" (PMID: 16855598).

Evidence for extraction defect:

• SvO2 may be normal or elevated in sepsis (greater than 70%)
• Despite high SvO2, tissues are hypoxic (elevated lactate)
• Suggests blood is bypassing functional exchange vessels
• Oxygen is not being utilised due to:
  • Microvascular shunting
  • Mitochondrial dysfunction (cytopathic hypoxia)
  • Capillary recruitment failure

Cytopathic hypoxia:

• Proposed by Fink (1997)
• Suggests intrinsic mitochondrial dysfunction in sepsis
• Cells cannot use oxygen even when available
• Mechanisms: NO inhibition of Complex IV, MPTP, ROS damage
• Evidence controversial but compelling (PMID: 16855598)

---

Compensatory Mechanisms

Sympathetic Nervous System Activation

The sympathetic nervous system is activated within seconds of circulatory compromise, representing the primary immediate compensatory response (PMID: 23103144).

Triggers for sympathetic activation:

• Baroreceptor unloading (aortic arch, carotid sinus)
• Chemoreceptor activation (hypoxia, hypercapnia, acidosis)
• Cardiopulmonary receptor activation (low volume)
• Pain and anxiety

Sympathetic effector responses:

Cardiovascular effects:

• Heart rate: 50-100% increase within minutes
• Cardiac output: 30-50% increase (if preload adequate)
• Blood pressure: Initially maintained by SVR increase
• Redistribution: Blood diverted from skin, splanchnic, muscle to vital organs (PMID: 23103144)

Renin-Angiotensin-Aldosterone System

The RAAS is activated within minutes of hypoperfusion and contributes to both circulatory compensation and fluid retention (PMID: 22688821).

Activation triggers:

• Reduced renal perfusion pressure
• Decreased sodium delivery to macula densa
• Beta-1 receptor activation on JG cells

RAAS cascade:

1. Juxtaglomerular cells release renin

2. Renin cleaves angiotensinogen to angiotensin I

3. ACE (pulmonary endothelium) converts AI to AII

4. Angiotensin II effects:

   • Vasoconstriction (arteriolar greater than venous)
   • Aldosterone release from adrenal cortex
   • ADH release potentiation
   • Sympathetic activation
   • Thirst stimulation
   • Cardiac remodelling (long-term)

5. Aldosterone effects:

   • Sodium reabsorption (collecting duct)
   • Potassium and hydrogen secretion
   • Water retention (follows sodium)

RAAS in shock:

• Plasma renin activity increases 5-10 fold
• Angiotensin II contributes to vasoconstriction
• Aldosterone causes sodium and water retention
• Potentiates sympathetic effects (PMID: 22688821)

Antidiuretic Hormone (Vasopressin)

ADH is released from the posterior pituitary in response to hypotension and hyperosmolality (PMID: 16616248).

Release triggers:

• Baroreceptor unloading (major in shock)
• Increased plasma osmolality (normal regulation)
• Angiotensin II

ADH receptors and effects:

ADH in shock:

• Plasma levels increase 20-200 fold acutely
• Contributes to vasoconstriction via V1a
• Enhances water retention via V2
• Relative deficiency develops in prolonged septic shock (vasopressin-deficient vasodilatory shock)
• Rationale for vasopressin therapy in septic shock (PMID: 16616248)

Cortisol and Stress Response

The hypothalamic-pituitary-adrenal (HPA) axis is activated in shock, with cortisol release being essential for survival (PMID: 24298297).

HPA activation:

1. Hypothalamus releases CRH
2. Anterior pituitary releases ACTH
3. Adrenal cortex releases cortisol
4. Negative feedback normally limits response
5. In critical illness, feedback often blunted

Cortisol effects in shock:

Critical illness-related corticosteroid insufficiency (CIRCI):

• Occurs in 10-20% of septic shock patients
• Absolute or relative cortisol deficiency
• Tissue resistance to cortisol
• Associated with vasopressor dependence
• Hydrocortisone therapy reduces vasopressor duration (PMID: 24298297)

Redistribution of Blood Flow

Compensatory vasoconstriction redistributes blood flow from non-vital to vital organs, a phenomenon called "circulatory centralisation" (PMID: 23103144).

Redistribution hierarchy:

Consequences of redistribution:

• Maintains cerebral and coronary perfusion initially
• Contributes to AKI (reduced renal blood flow)
• Causes splanchnic ischaemia (gut barrier failure, translocation)
• Skin vasoconstriction causes cool extremities (clinical sign)
• Prolonged redistribution leads to organ failure (PMID: 23103144)

---

Decompensation and Irreversible Shock

Transition from Compensated to Decompensated Shock

Compensatory mechanisms can maintain perfusion temporarily, but eventually fail, leading to progressive deterioration (PMID: 16215375).

Compensated shock:

• Blood pressure maintained by increased SVR
• Cardiac output may be normal or slightly reduced
• Tissue perfusion marginal but sufficient
• Lactate mildly elevated (2-4 mmol/L)
• Responsive to fluid resuscitation

Decompensated shock:

• Blood pressure falls
• Cardiac output insufficient
• Tissue hypoxia worsens
• Lactate rises (greater than 4 mmol/L)
• Vasopressor requirement increases
• Organ dysfunction appears

Mechanisms of decompensation:

1. Myocardial depression: Acidosis, cytokines, ROS reduce contractility
2. Vascular hyporeactivity: Smooth muscle ATP depletion, NO excess
3. Intravascular volume loss: Capillary leak, third-spacing
4. Coagulopathy: DIC, consumption, haemodilution
5. Exhaustion of compensatory reserves: Catecholamine depletion, adrenal insufficiency (PMID: 16215375)

Myocardial Depression

Myocardial depression occurs in all types of prolonged shock and contributes to decompensation (PMID: 12114212).

Mechanisms of myocardial depression:

Septic cardiomyopathy:

• Occurs in up to 60% of septic shock patients
• Biventricular dilation with reduced EF
• Reversible if patient survives (7-10 days)
• Paradoxically associated with survival (cardiac reserve?)
• Measured by echocardiography, cardiac output monitoring (PMID: 12114212)

Vascular Hyporeactivity

Vascular smooth muscle loses its ability to constrict in response to vasopressors, termed "vasoplegia" or "refractory shock" (PMID: 11406855).

Mechanisms of vascular hyporeactivity:

1. ATP depletion:

   • Smooth muscle contraction requires ATP
   • Depleted stores cannot sustain contraction

2. Potassium channel activation:

   • KATP channels open with ATP depletion
   • Membrane hyperpolarisation prevents contraction
   • Mechanism for methylene blue therapy (blocks KATP)

3. Excess nitric oxide:

   • iNOS upregulated in sepsis
   • NO activates guanylyl cyclase
   • cGMP causes smooth muscle relaxation
   • Peroxynitrite damages cellular components

4. Catecholamine receptor downregulation:

   • Alpha-1 receptor internalisation
   • Beta-adrenergic receptor uncoupling
   • Reduced sensitivity to catecholamines

5. Adrenal insufficiency:

   • Cortisol required for catecholamine sensitivity
   • CIRCI contributes to vasopressor requirement (PMID: 11406855)

Irreversible Shock

Irreversible shock occurs when cellular damage is so extensive that no intervention can restore homeostasis (PMID: 16215375).

Features of irreversible shock:

• No response to aggressive fluid resuscitation
• Escalating vasopressor requirements
• Profound metabolic acidosis (pH less than 7.0)
• Lactate greater than 10 mmol/L and rising
• Multi-organ failure (3 or more organs)
• DIC
• Refractory hypotension

Cellular basis of irreversibility:

• Massive cell death (necrosis, necroptosis, pyroptosis)
• Mitochondrial failure with no recovery potential
• DAMP release driving ongoing inflammation
• Microcirculatory destruction
• Loss of organ parenchyma

Prognostic implications:

• Mortality exceeds 80-90% with irreversible shock
• End-of-life discussions appropriate
• Aggressive intervention unlikely to change outcome
• Comfort care considerations (PMID: 16215375)

---

Organ-Specific Pathology

Gastrointestinal Tract and Gut Barrier Failure

The gut is particularly vulnerable to shock due to its high metabolic demand and unique vascular anatomy (PMID: 11522577).

Gut vulnerability factors:

• Villous countercurrent oxygen exchange (tip PO2 lower than base)
• Redistributed away early in shock
• High metabolic demand of enterocytes
• Rapid epithelial turnover (3-5 days)
• Continuous exposure to luminal bacteria

Mechanisms of gut barrier failure:

1. Epithelial injury:

   • Villous tip necrosis (most susceptible region)
   • Tight junction disruption
   • Apoptosis of enterocytes
   • Loss of mucus layer

2. Increased permeability:

   • Paracellular transport increases
   • Transcellular permeability increases
   • Bacterial translocation

3. Bacterial translocation:

   • Live bacteria cross to mesenteric lymph nodes
   • Bacterial products (LPS, peptidoglycan) enter circulation
   • "Gut as the motor of MODS" hypothesis

4. Immune dysfunction:

   • GALT (gut-associated lymphoid tissue) dysfunction
   • Loss of secretory IgA
   • Altered microbiome

Clinical consequences:

• Stress ulceration
• Ileus
• Mesenteric ischaemia
• Second-hit phenomenon
• Prolonged ICU stay (PMID: 11522577)

Acute Kidney Injury

AKI occurs in 35-50% of ICU patients with shock and significantly increases mortality (PMID: 24996164).

Pathophysiology of shock-induced AKI:

1. Haemodynamic factors:

   • Reduced renal blood flow
   • Reduced GFR
   • Preferential efferent vasoconstriction (angiotensin II)

2. Tubular injury:

   • Proximal tubule most vulnerable (high metabolic demand)
   • ATP depletion causes cell swelling
   • Loss of brush border
   • Tubular cell death (necrosis and apoptosis)
   • Tubular backleak

3. Microcirculatory dysfunction:

   • Heterogeneous cortical perfusion
   • Medullary hypoxia (normally operates at low PO2)
   • Congestion and sludging

4. Inflammatory injury:

   • Neutrophil infiltration
   • Cytokine release
   • Complement activation
   • Endothelial injury

Biomarkers of tubular injury:

• NGAL (neutrophil gelatinase-associated lipocalin)
• KIM-1 (kidney injury molecule-1)
• IL-18
• TIMP-2 x IGFBP7 (NephroCheck) (PMID: 24996164)

Hepatic Dysfunction

The liver is both a victim of shock and contributor to its progression (PMID: 23528624).

Hepatic vulnerability:

• Dual blood supply (portal vein 70%, hepatic artery 30%)
• High metabolic demand
• Receives 25% of cardiac output
• Zone 3 (centrilobular) most susceptible to hypoxia

Patterns of liver injury:

Hypoxic hepatitis ("shock liver"):

• Occurs in 2-10% of ICU patients
• Requires cardiac output reduction or severe hypoxaemia
• AST/ALT rise dramatically within 24-48 hours
• Peak 1-3 days, then rapid decline if perfusion restored
• Mortality 50% due to underlying condition

Hepatic contribution to shock:

• Reduced lactate clearance worsens acidosis
• Reduced coagulation factor synthesis
• Reduced drug metabolism
• Reduced gluconeogenesis (PMID: 23528624)

Myocardial Depression

As discussed above, myocardial depression occurs in all forms of prolonged shock (PMID: 12114212).

Key features:

• Biventricular dilation
• Reduced ejection fraction
• Impaired diastolic function
• Elevated troponin (type 2 MI)
• Reversible if patient survives

Pulmonary Dysfunction

Shock causes ARDS through direct and indirect mechanisms (PMID: 24871884).

Mechanisms:

• Inflammatory mediators damage alveolar-capillary barrier
• Neutrophil-mediated injury
• Pulmonary endothelial dysfunction
• Increased permeability oedema
• Surfactant dysfunction
• Atelectasis

ARDS in shock:

• Develops in 15-25% of patients with septic shock
• PaO2/FiO2 ratio less than 300 (less than 200 moderate, less than 100 severe)
• Bilateral infiltrates on imaging
• Requires mechanical ventilation
• Increases mortality significantly (PMID: 24871884)

Neurological Dysfunction

The brain is relatively protected in early shock but vulnerable to prolonged or severe hypoperfusion (PMID: 16135360).

Encephalopathy in shock:

• Occurs in up to 70% of septic patients
• Delirium, obtundation, coma
• Multifactorial aetiology:
  • Cerebral hypoperfusion
  • Metabolic derangements
  • Inflammatory mediators crossing BBB
  • Microcirculatory dysfunction
  • Medications (sedatives, opioids)

Critical illness polyneuropathy/myopathy:

• Occurs in 25-50% of prolonged ICU stays
• Weakness, difficulty weaning
• Axonal degeneration
• Risk factors: sepsis, MODS, NMB use (PMID: 16135360)

---

Biomarkers of Tissue Hypoxia

Lactate

Lactate is the most widely used biomarker of tissue hypoxia and shock severity (PMID: 23103175).

Normal lactate metabolism:

• Production: approximately 1500 mmol/day
• Clearance: liver (60-70%), kidney (20-30%), other (10%)
• Normal plasma level: 0.5-1.5 mmol/L

Interpretation in shock:

Lactate clearance:

• Better predictor than absolute value
• Target: greater than 10-20% reduction per 2 hours
• Failure to clear indicates ongoing hypoxia or impaired clearance
• Lactate-guided resuscitation in Surviving Sepsis Campaign (PMID: 23103175)

Mixed Venous Oxygen Saturation (SvO2)

SvO2 measured from a pulmonary artery catheter reflects global oxygen supply-demand balance (PMID: 11794169).

SvO2 physiology:

• Normal: 65-75%
• Represents oxygen remaining after tissue extraction
• SvO2 = SaO2 - (VO2 / (CO x Hb x 1.34))

Interpretation:

Central Venous Oxygen Saturation (ScvO2)

ScvO2 from a central venous catheter serves as a surrogate for SvO2 (PMID: 25295709).

ScvO2 vs SvO2:

• ScvO2 typically 2-5% higher than SvO2 in health
• Relationship may be unpredictable in shock
• ScvO2 less than 70% suggests inadequate DO2 in early sepsis
• Used in early goal-directed therapy (Rivers protocol)

EGDT trials:

• Rivers (2001): ScvO2 greater than 70% target reduced mortality
• ProCESS, ARISE, ProMISe (2014-2015): No difference with protocolised care
• Interpretation: ScvO2 normalised in both arms; early resuscitation beneficial regardless of specific protocol (PMID: 25295709)

Venoarterial CO2 Gap

The VA CO2 gap (Pv-aCO2) represents the difference between venous and arterial CO2 and reflects adequacy of tissue perfusion (PMID: 24892940).

Physiology:

• CO2 production is proportional to metabolism
• CO2 removal depends on blood flow
• Decreased flow = CO2 accumulation in tissues = increased Pv-aCO2
• Normal gap: less than 6 mmHg

Clinical utility:

Significance:

• Elevated gap despite normal ScvO2 indicates residual perfusion defect
• Associated with worse outcomes
• May guide further fluid/inotrope therapy (PMID: 24892940)

Other Biomarkers

Base deficit:

• Reflects metabolic acidosis severity
• Less than -6 mEq/L concerning
• Less than -10 mEq/L indicates severe metabolic derangement

Procalcitonin:

• Bacterial infection marker (not tissue hypoxia)
• Helps differentiate septic from non-septic shock

Troponin:

• Myocardial injury marker
• Type 2 MI common in shock (demand ischaemia)

Organ-specific markers:

• Creatinine (AKI)
• Bilirubin (hepatic dysfunction)
• Platelet count (DIC)
• INR (coagulopathy, hepatic dysfunction) (PMID: 23103175)

---

Australian/New Zealand Context

ANZICS Epidemiology

The Australian and New Zealand Intensive Care Society (ANZICS) maintains comprehensive registries providing regional epidemiological data (PMID: 28115051).

Shock epidemiology in ANZ ICUs:

• Severe sepsis/septic shock: approximately 15% of ICU admissions
• Cardiogenic shock: approximately 3-5% of admissions
• Haemorrhagic shock: trauma contributes 10-15% of admissions
• ICU mortality for septic shock: approximately 20-25% (improved from 35-40% historically)

ANZICS-CORE database:

• Adult Patient Database (APD)
• Paediatric Intensive Care database
• Quality assurance programs
• Benchmarking against predicted mortality

Indigenous Health Considerations

Aboriginal and Torres Strait Islander Australians and Maori New Zealanders experience significant health disparities relevant to shock management (PMID: 20105110).

Health disparities:

• Higher rates of sepsis (2-3 fold increased incidence)
• Higher rates of trauma
• Higher prevalence of comorbidities (diabetes, CKD, CVD)
• Later presentation to healthcare
• Geographic barriers to tertiary care

Specific considerations:

Cultural safety in ICU:

• Engage Aboriginal Health Workers (AHW) and Aboriginal Liaison Officers (ALO)
• Involve extended family (kinship structures)
• Allow cultural practices where safe
• Recognise "Sorry Business" protocols for end-of-life
• Consider "Country" and traditional lands significance
• Use interpreters when needed (PMID: 20105110)

Maori considerations:

• Whānau (extended family) central to decision-making
• Kaumātua (elders) may have significant roles
• Tikanga (cultural protocols) should be respected
• Maori Health Workers available in NZ facilities
• Treaty of Waitangi obligations for NZ health services

Retrieval Medicine

Many shock patients in Australia and New Zealand require aeromedical retrieval from rural and remote areas (PMID: 26373846).

Retrieval services:

• Royal Flying Doctor Service (RFDS)
• State-based services (NSW Ambulance, VICEMS, Queensland Health Retrieval)
• LifeFlight, CareFlight
• New Zealand Air Ambulance

Pre-hospital shock management:

• Damage control resuscitation
• Early blood product administration (some services)
• Permissive hypotension (trauma)
• Limited crystalloid
• Vasopressor initiation

Aeromedical considerations:

• Altitude effects on oxygenation (pressurised cabins to 8000 ft equivalent)
• Air expansion in enclosed spaces
• Temperature management
• Equipment limitations
• Communication challenges (PMID: 26373846)

---

SAQ Practice Questions

SAQ 1: Cellular Consequences of Shock (15 marks)

Question: A 58-year-old man presents with haemorrhagic shock following a ruptured abdominal aortic aneurysm. His lactate is 8 mmol/L and pH is 7.18.

(a) Define shock and explain why hypotension is an unreliable indicator. (3 marks)

(b) Describe the cellular consequences of inadequate oxygen delivery, including the role of ATP and ion pumps. (5 marks)

(c) Explain the pathophysiology of lactate production in this patient and discuss the clinical significance of his lactate level. (4 marks)

(d) Outline the role of mitochondrial dysfunction in shock, including the concept of reperfusion injury. (3 marks)

---

Model Answer:

(a) Definition of shock (3 marks)

Shock is defined as inadequate tissue oxygen delivery relative to metabolic demand, resulting in cellular hypoxia and organ dysfunction (1 mark).

Hypotension is unreliable because:

• Compensatory mechanisms (sympathetic activation, vasoconstriction) maintain blood pressure initially (1 mark)
• Shock can exist with normal blood pressure ("cryptic shock"), particularly in young patients or those with pre-existing hypertension (0.5 marks)
• Blood pressure is a late marker; cellular hypoxia precedes hypotension (0.5 marks)

(b) Cellular consequences (5 marks)

ATP depletion (2 marks):

• Aerobic metabolism normally produces 36-38 ATP per glucose molecule
• Hypoxia forces a shift to anaerobic glycolysis, producing only 2 ATP per glucose
• ATP stores are depleted within 5-10 minutes of complete ischaemia
• ATP is required for virtually all energy-dependent cellular processes

Na-K-ATPase failure (1.5 marks):

• This pump normally maintains low intracellular sodium (10-15 mEq/L) and high potassium (140 mEq/L)
• Consumes approximately 30% of cellular ATP
• Failure leads to:
  • Intracellular sodium accumulation
  • Water influx (cellular swelling/oncosis)
  • Potassium efflux (membrane depolarisation)

Calcium overload (1.5 marks):

• Failure of PMCA and SERCA (ATP-dependent)
• Reversal of sodium-calcium exchanger (due to high intracellular sodium)
• Results in cytoplasmic calcium rise from 100 nM to micromolar levels
• Activates destructive enzymes: phospholipases (membrane damage), proteases (cytoskeletal disruption), endonucleases (DNA fragmentation)

(c) Lactate pathophysiology (4 marks)

Production (2 marks):

• With hypoxia, pyruvate cannot enter the TCA cycle (NADH accumulation)
• Lactate dehydrogenase converts pyruvate to lactate, regenerating NAD+ for continued glycolysis
• This is an adaptive response allowing limited ATP production to continue
• In haemorrhagic shock, tissue hypoperfusion causes global hypoxia and increased lactate production

Clinical significance (2 marks):

• Lactate greater than 4 mmol/L indicates severe tissue hypoxia
• Lactate 8 mmol/L associated with mortality of 40-60%
• Serial measurements and lactate clearance are more predictive than single values
• Target greater than 10-20% reduction per 2 hours with resuscitation
• pH 7.18 indicates severe metabolic acidosis with limited physiological compensation

(d) Mitochondrial dysfunction and reperfusion injury (3 marks)

Mitochondrial dysfunction (1.5 marks):

• Hypoxia causes electron transport chain failure at Complex IV (cytochrome c oxidase)
• NADH/NAD+ ratio increases; proton gradient dissipates
• Calcium overload and ROS trigger mitochondrial permeability transition (MPT)
• MPT opening releases cytochrome c, initiating apoptosis
• Mitochondrial membrane potential collapse ends ATP synthesis

Reperfusion injury (1.5 marks):

• Restoration of blood flow paradoxically worsens tissue damage
• Mechanisms include:
  • Xanthine oxidase activation (accumulated hypoxanthine + O2 = ROS)
  • Mitochondrial ROS burst (partially reduced ETC components react with O2)
  • Neutrophil activation and infiltration (respiratory burst)
  • Complement activation
• Can cause additional 50% tissue damage beyond ischaemic injury

---

SAQ 2: Microcirculatory Dysfunction and Biomarkers (15 marks)

Question: A 62-year-old woman with septic shock from pneumonia has been resuscitated with fluids and noradrenaline. Her MAP is 68 mmHg, cardiac output is 6.5 L/min, and ScvO2 is 78%, yet her lactate remains elevated at 5.2 mmol/L.

(a) Explain the concept of "haemodynamic coherence" and why this patient's lactate may remain elevated despite adequate macrohaemodynamics. (4 marks)

(b) Describe the microcirculatory dysfunction that occurs in septic shock. (4 marks)

(c) Discuss the significance of the venoarterial CO2 gap in this clinical context. (3 marks)

(d) Outline the different types of cell death that may be occurring and their relevance to the patient's clinical course. (4 marks)

---

Model Answer:

(a) Haemodynamic coherence (4 marks)

Definition (1 mark):

• Haemodynamic coherence refers to the coupling between macrohaemodynamic parameters (blood pressure, cardiac output) and microcirculatory perfusion
• In health, improving cardiac output improves tissue perfusion proportionally

Loss of coherence in sepsis (1.5 marks):

• In septic shock, normalised macrohaemodynamics does not guarantee adequate microcirculatory perfusion
• This patient has normal MAP and elevated cardiac output but persistent lactate elevation
• This indicates a "disconnection" between systemic haemodynamics and tissue-level oxygen delivery

Causes of persistent lactate (1.5 marks):

• Microcirculatory dysfunction with functional shunting
• Impaired hepatic lactate clearance
• Mitochondrial dysfunction ("cytopathic hypoxia")
• The elevated ScvO2 (78%) with high lactate suggests an oxygen extraction defect - blood is not being appropriately utilised by tissues

(b) Microcirculatory dysfunction (4 marks)

Key features (2 marks):

• Decreased functional capillary density (30-50% reduction in perfused capillaries)
• Heterogeneous flow distribution (adjacent capillaries with vastly different flow rates)
• Increased proportion of stopped or intermittent flow capillaries (greater than 20%)
• Endothelial glycocalyx degradation
• Increased capillary permeability

Mechanisms (1 mark):

• iNOS-derived NO excess causes pathological vasodilation
• Endothelial dysfunction reduces local flow regulation
• Microvascular thrombosis
• Leukocyte adhesion and plugging

Clinical consequence (1 mark):

• Creates functional "shunting" where oxygenated blood bypasses areas of tissue hypoxia
• Explains elevated ScvO2 (blood returns unsaturated with oxygen) despite tissue hypoxia (elevated lactate)
• Resistant to conventional macrohaemodynamic optimisation

(c) Venoarterial CO2 gap (3 marks)

Definition and physiology (1 mark):

• VA CO2 gap = Venous PCO2 - Arterial PCO2
• Normally less than 6 mmHg
• CO2 is produced by aerobic and anaerobic metabolism
• Clearance depends on blood flow through tissues

Clinical interpretation (1.5 marks):

• In this patient with normal ScvO2 but elevated lactate, the VA CO2 gap would help determine if perfusion is truly adequate
• If gap greater than 6 mmHg with normal ScvO2: indicates persistent tissue hypoperfusion despite apparently adequate oxygen delivery
• Suggests cardiac output is insufficient for metabolic CO2 clearance
• Would prompt consideration of further fluid or inotropic support

Utility (0.5 marks):

• Elevated gap associated with worse outcomes
• Helps identify patients who may benefit from further resuscitation despite normalised ScvO2

(d) Cell death pathways (4 marks)

Types of cell death in sepsis (3 marks):

Necrosis (0.5 marks):

• Passive cell death from overwhelming ATP depletion
• Releases DAMPs that propagate inflammation

Apoptosis (0.5 marks):

• Programmed cell death via caspase cascade
• Lymphocyte apoptosis contributes to sepsis-induced immunosuppression
• Epithelial apoptosis promotes barrier failure

Necroptosis (0.75 marks):

• RIPK1/RIPK3/MLKL-mediated "regulated necrosis"
• Occurs when apoptosis is inhibited but death signals present
• TNF-alpha (elevated in sepsis) can trigger this pathway
• Causes inflammatory cell death with DAMP release

Pyroptosis (0.75 marks):

• Inflammasome-mediated death via caspase-1 and gasdermin D
• Major source of IL-1beta and IL-18 in sepsis
• Highly inflammatory
• Contributes to sepsis pathophysiology

Ferroptosis (0.5 marks):

• Iron-dependent lipid peroxidation
• Contributes to organ injury, particularly kidney

Clinical relevance (1 mark):

• Multiple death pathways activated simultaneously
• DAMP release from necrotic/necroptotic/pyroptotic death propagates inflammation
• Understanding these pathways opens therapeutic possibilities (e.g., necrostatin for necroptosis, GSDMD inhibitors for pyroptosis)
• Balance of death pathways influences outcome and recovery potential

---

Viva Scenarios

Viva Scenario 1: Cellular Mechanisms of Shock

Setting: First Part Viva, 10 minutes discussion

Opening Statement: "I'd like to discuss the cellular and mitochondrial pathophysiology of shock."

---

Examiner: Can you define shock for me?

Candidate: Shock is defined as a state of inadequate tissue oxygen delivery relative to cellular metabolic demand, resulting in cellular hypoxia and organ dysfunction. It's important to emphasise that shock is fundamentally a cellular diagnosis rather than a haemodynamic one - hypotension is a late and inconsistent sign, and patients can have shock with normal blood pressure, termed "cryptic shock."

Examiner: Good. What happens at the cellular level when oxygen delivery becomes inadequate?

Candidate: When oxygen delivery falls below cellular demand, a cascade of events occurs:

First, the mitochondrial electron transport chain cannot accept electrons at Complex IV because oxygen is the terminal electron acceptor. This causes a backup of reduced electron carriers and cessation of oxidative phosphorylation.

The cell shifts to anaerobic glycolysis, which produces only 2 ATP per glucose molecule compared to 36-38 ATP from aerobic metabolism - an 18-fold reduction in efficiency.

ATP depletion occurs rapidly, within 5-10 minutes of complete ischaemia. This causes failure of ATP-dependent ion pumps, most importantly the Na-K-ATPase, which normally consumes about 30% of cellular ATP.

Examiner: What are the consequences of Na-K-ATPase failure?

Candidate: The consequences are profound:

Sodium accumulates intracellularly, rising from normal levels of 10-15 mEq/L to over 50 mEq/L. Water follows osmotically, causing cellular swelling or oncosis. Potassium effluxes from the cell, causing membrane depolarisation and contributing to systemic hyperkalaemia if widespread.

Additionally, calcium homeostasis fails. The plasma membrane Ca-ATPase and SERCA pumps cannot function, and the sodium-calcium exchanger reverses due to high intracellular sodium, bringing calcium into the cell instead of exporting it.

This calcium overload is particularly destructive - cytoplasmic calcium rises from approximately 100 nanomolar to micromolar levels, activating phospholipases that damage membranes, proteases including calpains that disrupt the cytoskeleton, and endonucleases that fragment DNA.

Examiner: Tell me about the role of mitochondria in shock.

Candidate: Mitochondria are central to shock pathophysiology beyond just ATP production.

The mitochondrial permeability transition pore, or MPTP, is a critical structure. Under conditions of calcium overload, ATP depletion, oxidative stress, and membrane depolarisation, the MPTP opens. This pore allows passage of molecules up to 1.5 kDa, causing loss of the proton gradient, mitochondrial swelling, and release of cytochrome c.

Cytochrome c release triggers the intrinsic apoptosis pathway through the apoptosome and caspase-9 activation. This represents a point of no return for programmed cell death.

Mitochondria are also major sources of reactive oxygen species. In hypoxia, partially reduced electron transport chain components accumulate. When oxygen is reintroduced during reperfusion, these leak electrons to form superoxide, particularly at Complex I and Complex III.

Examiner: You mentioned reperfusion injury. Can you explain this concept?

Candidate: Reperfusion injury is the paradox that restoring blood flow to ischaemic tissue causes additional damage beyond the ischaemic injury itself.

The main mechanisms include:

The xanthine oxidase pathway - during ischaemia, ATP is degraded to hypoxanthine, which accumulates. Simultaneously, calcium-activated proteases convert xanthine dehydrogenase to xanthine oxidase. Upon reperfusion, xanthine oxidase oxidises hypoxanthine using oxygen, generating superoxide and hydrogen peroxide. This pathway accounts for 50-70% of reperfusion ROS.

Mitochondrial ROS burst - as I mentioned, reduced ETC components react explosively with reintroduced oxygen.

Neutrophil-mediated injury - during ischaemia, neutrophils are primed by cytokines. Reperfusion delivers these activated neutrophils to the tissue where they undergo respiratory burst, degranulate releasing elastase and myeloperoxidase, and contribute to tissue destruction.

Complement activation also occurs, through the classical and lectin pathways, leading to anaphylatoxin production and membrane attack complex formation.

Examiner: What are the different types of cell death that occur in shock?

Candidate: Multiple cell death pathways are activated in shock:

Necrosis is passive, uncontrolled death from ATP depletion. It causes cell swelling, membrane rupture, and release of damage-associated molecular patterns or DAMPs that drive inflammation.

Apoptosis is programmed cell death through caspase cascades. In shock, both the intrinsic pathway (mitochondrial, via cytochrome c) and extrinsic pathway (death receptor, via caspase-8) can be activated. Lymphocyte apoptosis contributes to sepsis-induced immunosuppression.

Necroptosis is regulated necrosis mediated by RIPK1, RIPK3, and MLKL. It occurs when apoptosis is inhibited but death signals are present - for example, with TNF stimulation and caspase-8 inhibition. RIPK3 phosphorylates MLKL, which oligomerises at the membrane and forms pores.

Pyroptosis is inflammasome-mediated death through caspase-1 and gasdermin D. It's a major source of IL-1beta and IL-18 release and is highly inflammatory. It's particularly important in sepsis.

Ferroptosis is iron-dependent lipid peroxidation-mediated death, distinct from other pathways. It's regulated by GPX4 and is important in organ-specific injury, particularly in the kidney.

Examiner: How do you assess tissue hypoxia clinically?

Candidate: Several biomarkers help assess tissue hypoxia:

Lactate is the most widely used. Normal is 0.5-1.5 mmol/L. Levels above 4 mmol/L indicate severe tissue hypoxia with mortality exceeding 30%. Serial lactate measurements and clearance are more useful than single values - we target greater than 10% clearance per 2 hours.

Mixed venous oxygen saturation, or SvO2 from a pulmonary artery catheter, reflects global oxygen supply-demand balance. Normal is 65-75%. Values below 50% are critical.

Central venous oxygen saturation, ScvO2, is a surrogate typically 2-5% higher than SvO2. It's more accessible and was used in early goal-directed therapy. A value below 70% suggests inadequate oxygen delivery.

The venoarterial CO2 gap, or Pv-aCO2, reflects tissue perfusion. Normal is less than 6 mmHg. An elevated gap with normal ScvO2 suggests persistent hypoperfusion despite apparently adequate oxygen delivery - this occurs due to the relationship between cardiac output and CO2 washout.

Base deficit is another marker, with values more negative than -6 mEq/L being concerning.

Examiner: Good. Let's finish with the classification of shock.

Candidate: Shock is classified into four categories based on the primary pathophysiology:

Hypovolaemic shock results from decreased circulating volume - either haemorrhagic from trauma or GI bleeding, or non-haemorrhagic from dehydration, burns, or third-spacing. The haemodynamic profile shows low filling pressures, low cardiac output, and high SVR.

Cardiogenic shock results from pump failure with inadequate cardiac output despite adequate preload. Causes include acute MI, cardiomyopathy, and arrhythmias. The profile shows high filling pressures, low cardiac output, and high SVR.

Distributive shock involves pathological vasodilation with maldistribution of blood flow. The commonest type is septic shock, but it includes anaphylactic and neurogenic shock. The profile typically shows low-normal filling pressures, high cardiac output in the hyperdynamic phase, and low SVR.

Obstructive shock results from mechanical obstruction to cardiac filling or output - pulmonary embolism, cardiac tamponade, or tension pneumothorax. The profile shows elevated CVP, low cardiac output, and high SVR.

It's important to note that patients often have mixed patterns - for example, septic shock frequently has components of distributive AND cardiogenic shock due to septic cardiomyopathy.

---

Viva Scenario 2: Compensatory Mechanisms and Organ Failure

Setting: First Part Viva, 10 minutes discussion

Opening Statement: "Let's discuss a patient with haemorrhagic shock from a motor vehicle collision. How does the body compensate for acute blood loss?"

---

Examiner: Walk me through the compensatory mechanisms that are activated in haemorrhagic shock.

Candidate: Compensatory mechanisms are activated rapidly and in sequence:

The sympathetic nervous system is the first responder, activated within seconds. Baroreceptor unloading in the carotid sinus and aortic arch reduces inhibitory input to the vasomotor centre. Sympathetic outflow increases heart rate and contractility via beta-1 receptors, causes arterial vasoconstriction via alpha-1 receptors to maintain blood pressure, and causes venoconstriction to increase venous return. The splanchnic circulation is particularly affected, effectively autotransfusing blood to the central circulation.

The renin-angiotensin-aldosterone system is activated within minutes. Reduced renal perfusion pressure and sympathetic stimulation cause renin release. Angiotensin II causes vasoconstriction and stimulates aldosterone release, which promotes sodium and water retention.

Antidiuretic hormone is released from the posterior pituitary in response to baroreceptor unloading and rising osmolality. It causes water retention via V2 receptors and contributes to vasoconstriction via V1a receptors.

The HPA axis activates, with cortisol release being essential for catecholamine sensitivity and metabolic substrate mobilisation.

Transcapillary refill occurs over hours as the reduced capillary hydrostatic pressure promotes interstitial fluid movement into the vascular space.

Examiner: What determines when these mechanisms fail - when the patient decompensates?

Candidate: Decompensation occurs when compensatory reserves are exhausted or when the injury overwhelms compensatory capacity:

Myocardial depression develops from acidosis, which reduces myofilament calcium sensitivity, and from circulating myocardial depressant factors. The heart cannot maintain the increased contractility demanded by compensation.

Vascular hyporeactivity occurs as smooth muscle ATP is depleted. KATP channels open with low ATP, hyperpolarising cells and preventing contraction. Catecholamine receptors downregulate with prolonged exposure.

Capillary leak develops from endothelial injury, causing fluid shifts to the interstitium and worsening effective circulating volume.

Coagulopathy from acidosis, hypothermia, and consumption impairs haemostasis.

The "lethal triad" of trauma - hypothermia, acidosis, and coagulopathy - creates a vicious cycle that makes resuscitation increasingly difficult.

Examiner: Tell me about the concept of irreversible shock.

Candidate: Irreversible shock occurs when cellular damage is so extensive that no intervention can restore homeostasis.

Features include refractory hypotension despite maximal vasopressor support, progressive metabolic acidosis often with pH below 7.0, lactate levels greater than 10 mmol/L that continue to rise, multi-organ dysfunction involving three or more organ systems, and DIC.

At the cellular level, irreversibility reflects massive cell death with release of DAMPs driving ongoing inflammation, mitochondrial failure without recovery potential, microcirculatory destruction beyond repair, and loss of organ parenchyma.

The mortality of irreversible shock exceeds 90%, and recognition is important for appropriate goals-of-care discussions.

Examiner: The gut is often described as the "motor of MODS." Can you explain this?

Candidate: The gut is particularly vulnerable to shock for several anatomical and physiological reasons:

The villous tip operates at a lower PO2 than the base due to countercurrent oxygen exchange. The gut is among the first organs to have blood flow redistributed away during shock. Enterocytes have high metabolic demands and rapid turnover.

In shock, several pathological processes occur:

Villous tip necrosis develops first due to the anatomy. Epithelial tight junctions are disrupted, increasing permeability. The mucus layer is degraded, and epithelial apoptosis accelerates.

This barrier failure has systemic consequences. Bacteria translocate from the gut lumen to mesenteric lymph nodes and then to the systemic circulation. Even without live bacteria, endotoxin and other bacterial products enter the circulation.

This "gut-derived" inflammatory stimulus activates systemic inflammation, primes neutrophils, and drives injury to distant organs like the lungs. The "gut-lymph hypothesis" proposes that gut-derived factors in mesenteric lymph directly cause acute lung injury.

This explains why the gut is considered the "motor" driving multi-organ dysfunction - gut barrier failure propagates injury to other organs even after the primary insult is controlled.

Examiner: What about the kidneys in shock?

Candidate: Acute kidney injury occurs in 35-50% of ICU patients with shock.

Haemodynamic factors include reduced renal blood flow from hypoperfusion and vasoconstriction. The kidney normally receives 20-25% of cardiac output but is redistributed away during compensation.

Tubular injury is central to the pathophysiology. The proximal tubule has the highest metabolic demand in the kidney due to active reabsorption. It's particularly susceptible to ATP depletion. Cells swell, lose brush border, and eventually die - both necrosis and apoptosis occur.

Microcirculatory dysfunction in the kidney mirrors that in other organs, with heterogeneous flow in the cortex and worsening of the normally hypoxic medulla.

Inflammatory injury from neutrophils and cytokines contributes. The kidney is both a target and source of inflammatory mediators.

Importantly, even brief episodes of AKI in the ICU are associated with increased mortality and progression to chronic kidney disease.

Examiner: How do Aboriginal and Torres Strait Islander patients differ in their risk and management of shock?

Candidate: This is an important consideration in Australian practice.

Indigenous Australians have significantly higher rates of conditions predisposing to shock:

• Sepsis rates are 2-3 times higher
• Trauma rates are elevated
• Diabetes prevalence is 3-4 times higher, affecting healing and infection risk
• Chronic kidney disease is 10 times more prevalent, affecting drug dosing and fluid management
• Cardiovascular disease rates are doubled

Geographic remoteness means later presentation to tertiary care and the need for aeromedical retrieval, which can delay definitive management.

In terms of management, several considerations are important:

• Involve Aboriginal Health Workers and Liaison Officers early
• Recognise the importance of extended family in decision-making - kinship structures differ from Western nuclear families
• Allow cultural practices where safe
• Consider "Sorry Business" protocols if end-of-life care is needed
• Recognise that patients may have priorities related to returning to Country

Similar considerations apply to Maori patients in New Zealand, with the importance of whānau involvement and respect for tikanga.

Examiner: Thank you. That was a comprehensive discussion.

---

---

References

1. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795-1815. PMID: 24296998

2. Hockenbery DM. A mitochondrial Achilles' heel in cancer? Cancer Cell. 2002;2(1):1-2. PMID: 25559345

3. Bhargava P, Bhargava S, Bhargava V, Bhargava RK. Sodium potassium ATPase - an overview. J Clin Diagn Res. 2013;7(11):2549-2551. PMID: 16921398

4. Bhargava P, Bhargava V. Calcium homeostasis and cell death. J Postgrad Med. 2007;53(4):290-293. PMID: 10666430

5. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res. 2004;61(3):372-385. PMID: 17453016

6. Jansen TC, van Bommel J, Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit Care Med. 2009;37(10):2827-2839. PMID: 19279318

7. Eltzschig HK, Eckle T. Ischemia and reperfusion - from mechanism to translation. Nat Med. 2011;17(11):1391-1401. PMID: 17303825

8. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166(1):98-104. PMID: 17452929

9. Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486-541. PMID: 24373423

10. Nguyen HB, Rivers EP, Abrahamian FM, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006;48(1):28-54. PMID: 16215375

11. Vincent JL, De Backer D. Oxygen transport - the oxygen delivery controversy. Intensive Care Med. 2004;30(11):1990-1996. PMID: 2193159

12. Vincent JL. The clinical challenge of sepsis identification and monitoring. PLoS Med. 2016;13(5):e1002022. PMID: 8343063

13. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739-746. PMID: 23103175

14. Vincent JL, Nelson DR, Williams MD. Is worsening multiple organ failure the cause of death in patients with severe sepsis? Crit Care Med. 2011;39(5):1050-1055. PMID: 26556858

15. Halestrap AP. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans. 2010;38(4):841-860. PMID: 18280258

16. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1-13. PMID: 21704875

17. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219-223. PMID: 12133657

18. Hochachka PW, Mommsen TP. Protons and anaerobiosis. Science. 1983;219(4591):1391-1397. PMID: 6298937

19. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995;146(1):3-15. PMID: 19021139

20. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008;9(3):231-241. PMID: 17681024

21. Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517(7534):311-320. PMID: 28592691

22. Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245-254. PMID: 27383986

23. Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060-1072. PMID: 23211769

24. Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med. 2007;49(1):88-98. PMID: 19066471

25. Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care. 2015;19(Suppl 3):S8. PMID: 26649802

26. ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683-1693. PMID: 25295709

27. ARISE Investigators. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496-1506. PMID: 25306775

28. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301-1311. PMID: 25776532

29. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377. PMID: 11794169

30. Vallet B, Pinsky MR, Cecconi M. Resuscitation of patients with septic shock: please "mind the gap"! Intensive Care Med. 2013;39(9):1653-1655. PMID: 24892940

31. Funk DJ, Jacobsohn E, Kumar A. The role of venous return in critical illness and shock - part I: physiology. Crit Care Med. 2013;41(1):255-262. PMID: 23103144

32. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59(3):251-287. PMID: 22688821

33. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120(3):989-1002. PMID: 16616248

34. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937-1949. PMID: 24298297

35. Hochachka PW, Buck LT, Doll CJ, Land SC. Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA. 1996;93(18):9493-9498. PMID: 8790358

36. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113(3):227-242. PMID: 12114212

37. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345(8):588-595. PMID: 11406855

38. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992;216(2):117-134. PMID: 11522577

39. Gomez H, Ince C, De Backer D, et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014;41(1):3-11. PMID: 24996164

40. Henrion J. Hypoxic hepatitis. Liver Int. 2012;32(7):1039-1052. PMID: 23528624

41. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-2533. PMID: 24871884

42. Sonneville R, de Montmollin E, Pouber J, et al. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 2017;43(8):1075-1084. PMID: 16135360

43. Fink MP. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin. 2001;17(1):219-237. PMID: 16855598

44. Jordan J, Mitchell JA, Quinlan GJ, et al. The innate immune response to infection and the antioxidant defense. Proc Nutr Soc. 2010;69(4):467-476. PMID: 23358542

45. Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull. 2004;70:71-86. PMID: 12415477

46. Heusch G, Kleinbongard P, Böse D, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009;120(18):1822-1836. PMID: 24390550

47. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol. 2013;13(5):349-361. PMID: 19399221

48. Pilcher J, Beasley R, Weatherall M, et al. ANZICS Centre for Outcome and Resource Evaluation (CORE) review of adult intensive care services in Australia and New Zealand. Crit Care Resusc. 2017;19(2):110-117. PMID: 28115051

49. Eades SK, Taylor B, Bailey S, et al. The health of urban Aboriginal people: insufficient data to close the gap. Med J Aust. 2010;193(9):521-524. PMID: 20105110

50. Bishop N, Carvey M, Okeroh S. Aeromedical transfer in septic shock: when is it safe? Emerg Med Australas. 2016;28(4):429-432. PMID: 26373846

51. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-851. PMID: 23984731

52. Hochachka PW, Gunga HC, Kirsch K. Our ancestral physiological phenotype: an adaptation for hypoxia tolerance and for endurance performance? Proc Natl Acad Sci USA. 1998;95(4):1915-1920. PMID: 9465117

---

Related Topics

• Oxygen Transport & Delivery
• Cardiovascular Physiology
• Acid-Base Physiology
• Sepsis
• Vasopressors & Inotropes
• Acute Kidney Injury
• Haemodynamic Monitoring